Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Catapres-TTS
Clonidine 2.5mg
Transdermal patch
Boehringer Ingelheim (NZ) Limited
Alza Corporation, California, United States of America

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Catapres-TTS
Clonidine 5mg
Transdermal patch
Boehringer Ingelheim (NZ) Limited
Alza Corporation, California, United States of America

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Catapres-TTS
Clonidine 7.5mg
Transdermal patch
Boehringer Ingelheim (NZ) Limited
Alza Corporation, California, United States of America

Product:
Active Ingredients:


Dosage Form:
New Zealand Sponsor:
Manufacturer:

Duolin
Ipratropium bromide monohydrate 0.021mg
equivalent to Ipratropium bromide anhydrous 0.020mg;
Salbutamol sulfate 0.12mg equivalent to Salbutamol 0.100mg
Aerosol inhaler, metered dose
REX Medical Limited
Cipla Limited, Goa, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Eliquis
Apixaban 2.5mg
Film coated tablet
Pfizer New Zealand Limited
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Eliquis
Apixaban 5mg
Film coated tablet
Pfizer New Zealand Limited
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Priligy
Dapoxetine hydrochloride 33.6mg equivalent to Dapoxetine 30mg
Film coated tablet
Te Arai Biofarma Limited
Janssen Ortho LLC, Gurabo, Puerto Rico
Menarini – Von Heyden GmbH, Dresden, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Priligy
Dapoxetine hydrochloride 67.2mg equivalent to Dapoxetine 60mg
Film coated tablet
Te Arai Biofarma Limited
Janssen Ortho LLC, Gurabo, Puerto Rico
Menarini – Von Heyden GmbH, Dresden, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Xolair
Omalizumab 75mg
Injection with diluent
Novartis New Zealand Limited
Genentech Inc, California, United States of America
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Xolair
Omalizumab 150mg
Injection with diluent
Novartis New Zealand Limited
Genentech Inc, California, United States of America
Novartis Pharma Stein AG, Stein, Switzerland